WO2004032895A1 - Use of detergents with a quotient from the haemolysis value and denaturing index of greater than or equal to 1 for achieving or increasing the selectivity of cleaning preparations - Google Patents

Use of detergents with a quotient from the haemolysis value and denaturing index of greater than or equal to 1 for achieving or increasing the selectivity of cleaning preparations Download PDF

Info

Publication number
WO2004032895A1
WO2004032895A1 PCT/EP2002/010819 EP0210819W WO2004032895A1 WO 2004032895 A1 WO2004032895 A1 WO 2004032895A1 EP 0210819 W EP0210819 W EP 0210819W WO 2004032895 A1 WO2004032895 A1 WO 2004032895A1
Authority
WO
WIPO (PCT)
Prior art keywords
cleaning
use according
sodium
cleaning preparations
surfactants
Prior art date
Application number
PCT/EP2002/010819
Other languages
German (de)
French (fr)
Inventor
Manfred Strassner
Stephan Ruppert
Andreas Schepky
Jens-Peter Vietzke
Harald Albrecht
Urte Maerker
Ralph Schimpf
Joachim Ennen
Claudius Rapp
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Priority to PCT/EP2002/010819 priority Critical patent/WO2004032895A1/en
Publication of WO2004032895A1 publication Critical patent/WO2004032895A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers

Definitions

  • the present invention relates to the use of surfactants with a quotient of hemolysis value and denaturation index of greater than or equal to 1 for achieving or increasing the selectivity of cosmetic or dermatological cleaning preparations.
  • Known agents for cleaning and simultaneous care of the skin are e.g. B. oil-containing cleaning preparations or cleaning preparations with different moisturizers or skin humidifiers, which are to re-grease or moisturize the skin during cleaning.
  • B. oil-containing cleaning preparations or cleaning preparations with different moisturizers or skin humidifiers which are to re-grease or moisturize the skin during cleaning.
  • the prior art knows, for example, oil bath preparations of various types and shower oils, cleaning creams and the like.
  • Selective cleaning preparations in the sense of the present invention wash out significantly more surface or sebum lipids than barrier lipids. If the ratio of washed-out surface or sebum lipids to washed-out barrier lipids is determined, this is the case for preparations containing surfactants used according to the invention with a quotient L / D of greater than or equal to 1, preferably greater than or equal to 3, particularly preferably greater than or equal to 5 significantly greater than 1.
  • the selectivity of a cleaning preparation can be increased according to the invention, for. B. in comparison to water.
  • products can be formulated which remove dirt and excess sebum with high selectivity and thereby protect the skin's own lipids, which are essential for preventing the skin from drying out.
  • the quotient L / D represents the ratio of the hemolysis value (L) to the denaturing index (D) and is determined by the standard RBC test.
  • the standard RBC test is used to estimate in vivo eye mucosal irritation potentials of surfactants and products containing surfactants. The process is based on the fact that surfactants interact strongly with cell membranes and proteins. Both effects are determined photometrically by analysis of the natural blood pigment oxyhemoglobin (Hb02). In contrast to other cell-based systems, the RBC test is able to differentiate between damage to the cell membrane (hemolysis) and protein denaturation (denaturation index). Fresh samples of calf blood are obtained directly from the slaughterhouse. The red blood cells are washed and centrifuged several times to separate the white blood cells and from all plasma residues. 1.
  • Hemolysis A defined aliquot of isolated calf erythrocytes is incubated with a series of increasing concentrations of the samples to be investigated containing wash-active substances (stock solution for raw materials 0.1% by weight active content of the wash-active substance in PBS) for 10 minutes with shaking at RT.
  • PBS is a common standard phosphate buffer (pH 7.4) with the following composition:
  • the incubation period is ended by high speed, high speed centrifugation. After centrifugation, the supernatants obtained are analyzed photometrically for their content of released hemoglobin (Hb02) at 530nm. From this, the relative degree of hemolysis based on 100% hemolysis is calculated and the L value [ ⁇ l / ml] (generally also referred to as the H50 value) is determined as a parameter from the concentration-response curve. This indicates the concentration of the test sample at which 50% of the hemoglobin is released.
  • a defined aliquot of isolated calf erythrocytes is incubated with a fixed concentration of the test sample (for surfactants: 0.1% active content in PBS) for 10 minutes with shaking at room temperature and then centrifuged quickly.
  • the change in spectral absorption at 575 nm and 540 nm is measured in comparison to the native Hb02.
  • the denaturation index D [%] is calculated from the ratio of the absorption values to one another. Na lauryl sulfate (0.1% active content) serves as the 100% standard.
  • L / D quotient The quotient represents the ratio of the parameters of hemolysis (L) and denaturation index (D) and is used to classify and characterize the test samples examined. The procedure is also recorded in the INVITTOX database for depositing animal experiment alternatives under Protocol No. 37 and is also described in the following references:
  • the surfactant or surfactants to be used according to the invention are advantageously selected from the group of surfactants which have a quotient L / D from hemolysis value (L) and denaturation index (D) of greater than or equal to 3, particularly preferably greater than or equal to 5.
  • the surfactant or surfactants to be used according to the invention are particularly advantageously selected from the group sodium N-alkyllyl glutamates, sodium alkyl sarcosinates, sodium alkyl sulfosuccinates and sodium salts of the ethoxylated and carboxylated triglycerides.
  • group sodium N-alkyllyl glutamates sodium alkyl sarcosinates, sodium alkyl sulfosuccinates and sodium salts of the ethoxylated and carboxylated triglycerides.
  • the surfactants sodium cocoyl glutamate, sodium lauroyl sarcosinate, disodium lauryl polyglycol ether sufosuccinate, sodium PEG-7 olive oil carboxylate.
  • the total amount of one or more surfactants used according to the invention in the finished cosmetic or dermatological preparations is advantageously chosen in the range from 0.1 to 10.0% by weight, preferably 0.5 to 5.0% by weight, in each case based on the total weight of the preparations.
  • the cleaning compositions containing surfactants used according to the invention can be composed as usual and can be used for cosmetic and / or dermatological cleaning of the skin and / or hair and as a make-up removal product for decorative cosmetics.
  • compositions comprising surfactants used according to the invention are applied to the skin and / or the hair in a sufficient amount in the manner customary for cosmetics.
  • Anionic surfactants to be used advantageously are acylamino acids (and their salts), such as 1. acylglutamates, for example sodium acylglutamate, di-TEA-palmitoylaspartate and sodium caprylic / capric glutamate,
  • acyl peptides for example palmitoyl hydrolyzed milk protein, sodium cocoyl hydrolyzed soy protein and sodium / potassium cocoyl hydrolyzed collagen,
  • sarcosinates for example myristoyl sarcosin, TEA-lauroyl sarcosinate, sodium lauroyl sarcosinate and sodium cocoyl sarcosinate,
  • taurates for example sodium lauroyl taurate and sodium methyl cocoyl taurate
  • Carboxylic acids and derivatives such as 1.
  • carboxylic acids for example lauric acid, aluminum stearate, magnesium alkanolate and zinc undecylenate,
  • ester carboxylic acids for example calcium stearoyl lactylate, laureth-6 citrate and sodium PEG-4 lauramide carboxylate
  • ether carboxylic acids for example sodium laureth-13 carboxylate and sodium PEG-6 cocamide carboxylate
  • Phosphoric acid esters and salts such as DEA-Oleth-10 phosphate and Dilureth-4 phosphate,
  • acyl isethionates e.g. Sodium / ammonium cocoyl isethionate
  • alkyl sulfonates for example sodium cocosmonoglyceride sulfate, sodium C 12-1 olefin sulfonate, sodium lauryl sulfoacetate and magnesium PEG-3 cocamide sulfate,
  • Sulfosuccinates for example dioctyl sodium sulfosuccinate, disodium laureth sulfosuccinate, disodium lauryl sulfosuccinate and disodium undecylenamido MEA sulfosuccinate
  • sulfuric acid esters such as
  • alkyl ether sulfate for example sodium, ammonium, magnesium, MIPA, TIPA laureth sulfate, sodium and sodium C12 pareth ⁇ 3,
  • Alkyl sulfates for example sodium, ammonium and TEA lauryl sulfate.
  • Quaternary surfactants contain at least one N atom that is covalently linked to 4 alkyl or aryl groups. Regardless of the pH value, this leads to a positive charge. Benzalkonium chloride, alkyl betaine, alkyl amidopropyl betaine and alkyl amidopropyl hydroxysultain are advantageous. C. Amphoteric surfactants
  • acyl / dialkyl ethylenediamine for example sodium acyl amphoacetate, disodium acyl amphodipropionate, disodium alkyl amphodiacetate, sodium acylamphohydroxypropyl sulfonate, disodium acylamphodiacetate and sodium acylamphopropionate,
  • N-alkylamino acids for example aminopropylalkylglutamide, alkylaminopropionic acid, sodium alkylimidodipropionate and lauroamphocarboxyglycinate.
  • N-alkyl or N-alkenyl betaines with at least 12 carbon atoms such as.
  • Nonionic surfactants to be used advantageously are I. alcohols,
  • alkanolamides such as cocamides MEA / DEA / MIPA
  • amine oxides such as cocoamidopropylamine oxide
  • esters which are formed by esterification of carboxylic acids with ethylene oxide, glycerol, sorbitan or other alcohols, 5.
  • ethers for example ethoxylated / propoxylated alcohols, ethoxylated / propoxylated esters, ethoxylated / propoxylated glycerol esters, ethoxylated / propoxylated cholesterols, ethoxylated / propoxylated Triglyceride esters, ethoxylated propoxylated lanolin, ethoxylated / propoxylated polysiloxanes, propoxylated POE ethers and alkyl polyglycosides such as lauryl glucoside, decyl glycoside and cocoglycoside. 6. sucrose esters, ether
  • the cleaning preparations within the meaning of the present invention particularly advantageously contain one or more wash-active surfactants according to the invention from the group of surfactants which have an HLB value of more than 25, very particularly those which have an HLB value of more than 35. It is advantageous in the sense of the present invention if the content of one or more detergent surfactants in the cosmetic or dermatological cleaning preparation is in the range from 1.5 to 20% by weight, very particularly advantageously from 2.0 to 15% by weight. % is selected, based in each case on the total weight of the preparation.
  • compositions within the meaning of the present invention further advantageously contain water and optionally the additives customary in cosmetics, e.g. B. preservatives, preservation aids, bactericides, perfumes, dyes, pigments that have a coloring effect, moisturizing and / or moisturizing substances, fillers that improve the feeling on the skin, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation.
  • the additives customary in cosmetics e.g. B. preservatives, preservation aids, bactericides, perfumes, dyes, pigments that have a coloring effect, moisturizing and / or moisturizing substances, fillers that improve the feeling on the skin, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation.
  • Advantageous preservatives for the purposes of the present invention are, for example, formaldehyde releasers (such as, for example, DMDM hydantoin, which is available, for example, from Lonza under the trade name Glydant TM), iodopropyl butyl carbamate (for example those under the trade names Glycacil) -L, Glycacil-S available from Lonza and / or Dekaben LMB from Jan Dekker), parabens (ie alkyl p-hydroxybenzoate, such as methyl, ethyl, propyl and / or butyl paraben), phenoxyethanol, Ethanol, benzoic acid and the like.
  • the preservation system usually also advantageously comprises preservation aids, such as, for example, octoxyglycerol, glycine soya, etc.
  • the water phase of the preparations can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those having a low C number, preferably ethanol and / or isopropanol, diols or polyols having a low C number, and their ethers, preferably propylene glycol, Glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, mono ethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analog products, polymers, foam stabilizers, electrolytes, dihydroxyacetone and in particular one or more thickeners, which or which advantageous can be selected from the group silicon dioxide, aluminum silicates, polysaccharides or their derivatives, for.
  • customary cosmetic auxiliaries such as, for example, alcohols, in particular those having a low C number, preferably ethanol and / or isopropanol, diols or polyo
  • Moisturizers are substances or mixtures of substances that give cosmetic or dermatological preparations the property of reducing the release of moisture from the horny layer (also known as trans-epidermal water loss (TEWL)) and / or hydrating the skin after application or distribution on the skin surface To influence the horny layer positively.
  • TEWL trans-epidermal water loss
  • moisturizers for the purposes of the present invention are, for example, glycerol, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccaride gum-1, glycine soya, ethylhexyloxyglycerol, pyrrolidonecarboxylic acid and urea.
  • polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gelable polysaccharides.
  • compositions are also obtained if antioxidants are used as additives or active ingredients.
  • the preparations advantageously contain one or more antioxidants. All of the antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as inexpensive, but nevertheless optional, antioxidants.
  • water-soluble antioxidants such as vitamins, e.g. B. ascorbic acid and its derivatives.
  • Preferred antioxidants are also vitamin E and its derivatives and vitamin A and its derivatives.
  • the amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight the preparation.
  • vitamin E and / or its derivatives represent the antioxidant (s)
  • vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to add their respective concentrations in the range from 0.001 to 10% by weight, based on the total weight of the formulation choose.
  • the cosmetic preparations according to the present invention contain cosmetic or dermatological active ingredients, preferred active ingredients being antioxidants which can protect the skin and / or the hair from oxidative stress.
  • active substances in the sense of the present invention are natural active substances and / or their derivatives, such as.

Abstract

The invention relates to the use of one or several surface-active substances, selected from the group of detergents which have a quotient from haemolysis value and denaturing index of greater than or equal to 1, for achieving or increasing the selectivity of cosmetic or dermatological cleaning preparations.

Description

Beiersdorf Aktiengesellschaft Beiersdorf Aktiengesellschaft
Beschreibungdescription
Verwendung von Tensiden mit einem Quotienten aus Hämolysewert und Denaturie- runqsindex von größer oder gleich 1 zum Erzielen oder Erhöhen der Selektivität von ReiniqungszubereitungenUse of surfactants with a quotient of hemolysis value and denaturation index of greater than or equal to 1 to achieve or increase the selectivity of cleaning preparations
Die vorliegende Erfindung betrifft die Verwendung von Tensiden mit einem Quotienten aus Hämolysewert und Denaturierungsindex von größer oder gleich 1 zum Erzielen oder Erhöhen der Selektivität von kosmetischen oder dermatologischen Reinigungszubereitungen.The present invention relates to the use of surfactants with a quotient of hemolysis value and denaturation index of greater than or equal to 1 for achieving or increasing the selectivity of cosmetic or dermatological cleaning preparations.
Bereits bei einer Reinigung der Haut mit Hilfe eines einfachen Wasserbads - ohne Zusatz von Tensiden - kommt es zunächst zu einer Quellung der Hornschicht der Haut. Der Grad dieser Quellung hängt u. a. von der Dauer des Bads und dessen Temperatur ab. Gleichzeitig werden wasserlösliche Stoffe ab- bzw. ausgewaschen, wie z. B. wasserlösli- ehe Schmutzbestandteile, aber auch hauteigene Stoffe, die für das Wasserbindungsvermögen der Hornschicht verantwortlich sind. Durch hauteigene oberflächenaktive Stoffe werden außerdem auch Hautfette (Oberflächen- und Barrierelipide) in gewissem Ausmaß gelöst und ausgewaschen.When the skin is cleaned with the help of a simple water bath - without the addition of surfactants - the horny layer of the skin swells. The degree of this swelling depends on a. on the duration of the bath and its temperature. At the same time, water-soluble substances are washed off or washed out, e.g. B. water-soluble dirt components, but also the skin's own substances, which are responsible for the water retention capacity of the horny layer. Skin oils (surface and barrier lipids) are also dissolved and washed out to a certain extent by the skin's own surface-active substances.
Während die gemeinsame Entfernung von Oberflächenschmutz und Oberflächenlipiden, welche vornehmlich aus den Talgdrüsen stammen und maßgeblich für das Erscheinungsbild der fettigen Haut verantwortlich sind, kosmetisch durchaus gewünscht ist, kann durch Auswaschen von Barrierelipiden die Funktion der Hautbarriere gestört werden, womit ein Feuchtigkeitsverlust der Haut verbunden ist. Dies geht einher mit einer zeitwei- sen Erhöhung des transepidermaien Wasserverlusts (TEWL) und einer zeitweisen Verringerung der Hautfeuchte. Vor allem bei Produkten zur Reinigung der empfindlichen Gesichtshaut und hier besonders bei Produkten für fettige Haut ist eine möglichst selektive Entfernung von Oberflächenschmutz, Make-up und Hauttalg für den Verbraucher besonders wichtig. Auf der anderen Seite bedarf vor allem die Gesichtshaut einer besonders schonenden Reinigung.While the removal of surface dirt and surface lipids, which originate primarily from the sebaceous glands and are largely responsible for the appearance of oily skin, is cosmetically desirable, washing out the barrier lipids can disrupt the function of the skin barrier, which is associated with a loss of moisture in the skin , This is accompanied by a temporary increase in transepidermal water loss (TEWL) and a temporary reduction in skin moisture. Especially in the case of products for cleaning the sensitive facial skin and here in particular in the case of products for oily skin, the most selective removal of surface dirt, make-up and skin sebum is for the consumer particularly important. On the other hand, the facial skin in particular needs particularly gentle cleaning.
Bei gesunder Haut sind die durch das Waschen verursachten Störungen im allgemeinen zeitlich begrenzt, da die Schutzmechanismen der Haut solche leichten Störungen der oberen Hautschichten ohne weiteres kompensieren können. Aber bereits im Fall nichtpathologischer Abweichungen vom Normalstatus - z. B. durch umweltbedingte Abnutzungsschäden bzw. Irritationen, Lichtschäden, Altershaut usw. - ist der Schutzmechanismus der Hautoberfläche gestört. Unter Umständen ist er dann aus eigener Kraft nicht mehr imstande, seine Aufgabe zu erfüllen und muß durch externe Maßnahmen regeneriert werden. Es hat daher nicht an Versuchen gefehlt, geeignete Reinigungszubereitungen zur besseren bzw. schnelleren Regeneration der Haut zu finden, die der Haut helfen, ihre natürliche Balance zu erhalten.In the case of healthy skin, the disorders caused by washing are generally limited in time, since the protective mechanisms of the skin can easily compensate for such slight disorders of the upper layers of the skin. But already in the case of non-pathological deviations from normal status - e.g. B. by environmental wear and tear or irritation, light damage, aging skin, etc. - the protective mechanism of the skin surface is disturbed. Under certain circumstances he may then no longer be able to fulfill his task on his own and must be regenerated by external measures. There has been no shortage of attempts to find suitable cleaning preparations for better or faster regeneration of the skin, which help the skin to maintain its natural balance.
Bekannte Mittel zur Reinigung und gleichzeitigen Pflege der Haut sind z. B. ölhaltige Reinigungszubereitungen oder Reinigungszubereitungen mit verschiedenen Rückfettern bzw. Hautbefeuchtern, welche die Haut bei der Reinigung gleichzeitig rückfetten bzw. befeuchten sollen. Der Stand der Technik kennt zu diesem Zweck beispielsweise Ölbadzubereitungen verschiedener Art sowie Duschöle, Reinigungscremes und dergleichen mehr.Known agents for cleaning and simultaneous care of the skin are e.g. B. oil-containing cleaning preparations or cleaning preparations with different moisturizers or skin humidifiers, which are to re-grease or moisturize the skin during cleaning. For this purpose, the prior art knows, for example, oil bath preparations of various types and shower oils, cleaning creams and the like.
Der Hauptnachteil derartiger Zubereitungen ist, daß ein Teil der Barrierelipide zunächst entfernt wird und eine Rückfettung der Haut anschließend mit Hilfe der zugesetzten Öl- komponenten erfolgt. Außerdem werden derartige Reinigungszubereitungen nach der Anwendung abgewaschen, so dass nur geringe Mengen der eingesetzten Additive auf der Haut verbleiben.The main disadvantage of such preparations is that part of the barrier lipids is first removed and the skin is then regreased with the help of the added oil components. In addition, cleaning preparations of this type are washed off after use, so that only small amounts of the additives used remain on the skin.
Es war daher Aufgabe der vorliegenden Erfindung, kosmetische oder dermatologische Zubereitungen zur Verfügung zu stellen, welche den Zustand der Haut deutlich verbes- sern, insbesondere die Hautrauhigkeit vermindern und welche sich durch eine Selektivität der Reinigungsleistung auszeichnen.It was therefore an object of the present invention to provide cosmetic or dermatological preparations which significantly improve the condition of the skin, in particular reduce the roughness of the skin and which are distinguished by a selectivity of the cleaning performance.
Es war überraschend und für den Fachmann in keiner Weise vorhersehbar, daß die Verwendung einer oder mehrerer grenzflächenaktiver Substanzen, gewählt aus der Gruppe der Tenside, welche einen Quotienten L/D aus Hämolysewert (L) und De- naturierungsindex (D) von größer oder gleich 1 aufweisen, zum Erzielen oder Erhöhen der Selektivität von kosmetischen oder dermatologischen Reinungszubereitun- gen, die Nachteile des Standes der Technik beseitigen würde.It was surprising and in no way foreseeable for the expert that the Use of one or more surface-active substances, selected from the group of surfactants, which have a quotient L / D from hemolysis value (L) and denaturation index (D) of greater than or equal to 1, in order to achieve or increase the selectivity of cosmetic or dermatological cleansing preparations - gene that would eliminate the disadvantages of the prior art.
Selektive Reinigungszubereitungen im Sinne der vorliegenden Erfindung waschen deutlich mehr Oberflächen- bzw. Sebumlipide als Barrierelipide aus. Bestimmt man also das Verhältnis von ausgewaschenen Oberflächen- bzw. Sebumlipiden zu ausgewaschenen Barrierelipiden, so ist dies für Zubereitungen enthaltend erfindungsgemäß verwendete Tenside mit einem Quotienten L/D von größer oder gleich 1 , bevorzugt größer oder gleich 3, besonders bevorzugt größer oder gleich 5, deutlich größer als 1. Die Steigerung der Selektivität einer Reinigungszubereitung läßt sich erfindungsgemäß z. B. im Vergleich zu Wasser bestimmen. Gemäß der vorliegenden Erfindung lassen sich Produkte formulieren, die mit hoher Selektivität Schmutz und überschüssiges Sebum entfernen und dabei die hauteigenen Lipide schonen, welche für die Verhinderung der Austrocknung der Haut essentiell sind.Selective cleaning preparations in the sense of the present invention wash out significantly more surface or sebum lipids than barrier lipids. If the ratio of washed-out surface or sebum lipids to washed-out barrier lipids is determined, this is the case for preparations containing surfactants used according to the invention with a quotient L / D of greater than or equal to 1, preferably greater than or equal to 3, particularly preferably greater than or equal to 5 significantly greater than 1. The selectivity of a cleaning preparation can be increased according to the invention, for. B. in comparison to water. According to the present invention, products can be formulated which remove dirt and excess sebum with high selectivity and thereby protect the skin's own lipids, which are essential for preventing the skin from drying out.
Der Quotient L/D repräsentiert das Verhältnis von Hämolysewert (L) zu Denaturierungs- index (D) und wird durch den Standard RBC-Test bestimmt.The quotient L / D represents the ratio of the hemolysis value (L) to the denaturing index (D) and is determined by the standard RBC test.
Der Standard RBC-Test dient zur Abschätzung von in-vivo Augenschleimhautreizpotenti- alen von Tensiden und tensidhaltigen Produkten. Das Verfahren beruht auf der Tatsache, dass Tenside stark mit Zellmembranen und Proteinen interagieren. Beide Effekte werden photometrisch durch Analyse des natürlichen Blutfarbstoffs Oxyhämoglobin (Hb02) bestimmt. Im Gegensatz zu anderen zeilbasierten Systemen ist der RBC-Test in der Lage zwischen Schädigungen der Zellmembran (Hämolyse) und Proteindenaturierung (Dena- turierungsindex) zu differenzieren. Frische Proben von Kälberblut werden direkt vom Schlachthaus bezogen. Die roten Blutzellen werden zur Abtrennung der weißen Blutzellen und von allen Plasmaresten mehrfach gewaschen und zentrifugiert. 1. Hämolyse: Ein definiertes Aliquot isolierter Kalbserythrozyten wird mit einer Reihe steigender Konzentration der zu untersuchenden, waschaktive Substanzen enthaltenden Muster (Stammlösung für Rohstoffe 0,1 Gew.-% Aktivgehalt der waschaktiven Substanz in PBS) für 10 Minuten unter Schütteln bei RT inkubiert. PBS ist ein üblicher Standard-Phosphat- Puffer (pH 7,4) mit folgender Zusammensetzung:The standard RBC test is used to estimate in vivo eye mucosal irritation potentials of surfactants and products containing surfactants. The process is based on the fact that surfactants interact strongly with cell membranes and proteins. Both effects are determined photometrically by analysis of the natural blood pigment oxyhemoglobin (Hb02). In contrast to other cell-based systems, the RBC test is able to differentiate between damage to the cell membrane (hemolysis) and protein denaturation (denaturation index). Fresh samples of calf blood are obtained directly from the slaughterhouse. The red blood cells are washed and centrifuged several times to separate the white blood cells and from all plasma residues. 1. Hemolysis: A defined aliquot of isolated calf erythrocytes is incubated with a series of increasing concentrations of the samples to be investigated containing wash-active substances (stock solution for raw materials 0.1% by weight active content of the wash-active substance in PBS) for 10 minutes with shaking at RT. PBS is a common standard phosphate buffer (pH 7.4) with the following composition:
Na2HP04 * 2 H20 3,95 gNa 2 HP0 4 * 2 H 2 0 3.95 g
KH2P04 0,76 gKH 2 P0 4 0.76 g
NaCI 7,20 gNaCI 7.20 g
Glucose * 1 H20 1 ,80 gGlucose * 1 H 2 0 1, 80 g
Aqua dest. oder „highly purified water" ad 1000 mlAqua dest. or "highly purified water" ad 1000 ml
Die Inkubationsperiode wird durch schnelle Hochgeschwindigkeitszentrifugation beendet. Nach Zentrifugation werden die gewonnenen Überstände photometrisch auf ihren Gehalt an freigesetztem Hämoglobin (Hb02) bei 530nm analysiert. Daraus wird der relative Hä- molysegrad bezogen auf 100%ige Hämolyse berechnet und der L-Wert [μl/ml] (i. A. auch als H50-Wert bezeichnet) als Kenngröße aus der Konzentrations-Response-Kurve bestimmt. Dieser gibt die Konzentration des Prüfmusters an, bei der 50% des Hämoglobins freigesetzt werden.The incubation period is ended by high speed, high speed centrifugation. After centrifugation, the supernatants obtained are analyzed photometrically for their content of released hemoglobin (Hb02) at 530nm. From this, the relative degree of hemolysis based on 100% hemolysis is calculated and the L value [μl / ml] (generally also referred to as the H50 value) is determined as a parameter from the concentration-response curve. This indicates the concentration of the test sample at which 50% of the hemoglobin is released.
2. Hb02-Denaturierungsindex:2. Hb02 denaturation index:
Ein definiertes Aliquot isolierter Kalbserythrozyten wird mit einer fixen Konzentration des Prüfmusters (bei Tensiden: 0,1% Aktivgehalt in PBS) für 10 Minuten unter Schütteln bei Raumtemperatur inkubiert und dann schnell zentrifugiert. Die Änderung der spektralen Absorption bei 575 nm und 540 nm wird im Vergleich zum nativen Hb02 gemessen. Aus dem Verhältnis der Absorptionswerte zueinander wird der Denaturierungsindex D [%] berechnet. Als 100%-Standard dient Na-Laurylsulfat (0,1% Aktivgehalt).A defined aliquot of isolated calf erythrocytes is incubated with a fixed concentration of the test sample (for surfactants: 0.1% active content in PBS) for 10 minutes with shaking at room temperature and then centrifuged quickly. The change in spectral absorption at 575 nm and 540 nm is measured in comparison to the native Hb02. The denaturation index D [%] is calculated from the ratio of the absorption values to one another. Na lauryl sulfate (0.1% active content) serves as the 100% standard.
L/D Quotient: Der Quotient stellt das Verhältnis der Kenngrößen von Hämolyse (L) und Denaturierungsindex (D) dar und wird zur Klassifizierung und Charakterisierung der untersuchten Prüfmuster verwendet. Das Verfahren ist auch in der INVITTOX-Datenbank zur Niederlegung von Tierversuchsalternativen unter Protokoll Nr. 37 niedergelegt und wird ferner in den folgenden Literaturstellen beschrieben:L / D quotient: The quotient represents the ratio of the parameters of hemolysis (L) and denaturation index (D) and is used to classify and characterize the test samples examined. The procedure is also recorded in the INVITTOX database for depositing animal experiment alternatives under Protocol No. 37 and is also described in the following references:
1. Kondo, T. (1976) Mechanisms of haemolysis by surface active agents. Adv. Colloid & Interface Sei., 6, 139-172 Kondo, T. & Tomizawa, M. (1968) Haemolysis by nonionic surface-active agents. J. Pharm. Sei., 57, 1246-1248.1. Kondo, T. (1976) Mechanisms of hemolysis by surface active agents. Adv. Colloid & Interface Sei., 6, 139-172 Kondo, T. & Tomizawa, M. (1968) Haemolysis by nonionic surface-active agents. J. Pharm. Sci., 57, 1246-1248.
2. Gloxhuber, Ch. (1974) Toxicological properties of surfaetants. Arch. Toxicol., 32, 245-270.2. Gloxhuber, Ch. (1974) Toxicological properties of surfaetants. Arch. Toxicol., 32, 245-270.
3. Pape, W.J.W., Pfannenbecker, U. & Hoppe, U. (1987) Validation of the red blood cell test as an in vitro assay for the rapid screening of irritation potential of surfaetants.3. Pape, W.J.W., Pfannenbecker, U. & Hoppe, U. (1987) Validation of the red blood cell test as an in vitro assay for the rapid screening of irritation potential of surfaetants.
Molecular Toxicology, 1 , 525-536.Molecular Toxicology, 1, 525-536.
4. Pape, W. & Hoppe, U. (1988) Second World Surfaetants Congress, Paris. Evaluation of acute irritation potentials of tensides using the in vitro alternative red blood cell test System. Proceedings, IV, 414-428. 5. Pape, W.J.W. (1990) In vitro methods for the assessment of local effects of cosmetics on skin and mueous membranes. Presented at: In-cosmetics 1990, Birmingham, UK.4. Pape, W. & Hoppe, U. (1988) Second World Surfaetants Congress, Paris. Evaluation of acute irritation potentials of tensides using the in vitro alternative red blood cell test system. Proceedings, IV, 414-428. 5. Pape, W.J.W. (1990) In vitro methods for the assessment of local effects of cosmetics on skin and mueous membranes. Presented at: In-cosmetics 1990, Birmingham, UK.
6. Pape, W.J.W. & Hoppe, U. (1991 ) Standardisation on an in vitro red blood cell test for evaluating the acute cytotoxic potential of tensides. Arzneimittel-Forschung/Drug Research, 40(l), 4, 498-502.6. Pape, W.J.W. & Hoppe, U. (1991) Standardization on an in vitro red blood cell test for evaluating the acute cytotoxic potential of tensides. Drug Research, 40 (l), 4, 498-502.
7. Pape, W.J.W. & Hoppe, U. (1991) In vitro methods for the assessment of primary local effects of topically applied preparations. Skin Pharmacology (in press).7. Pape, W.J.W. & Hoppe, U. (1991) In vitro methods for the assessment of primary local effects of topically applied preparations. Skin Pharmacology (in press).
Vorteilhaft werden das oder die erfindungsgemäß zu verwendenden Tenside aus der Gruppe der Tenside gewählt, welche einen Quotienten L/D aus Hämolysewert (L) und Denaturierungsindex (D) von größer oder gleich 3, besonders bevorzugt größer oder gleich 5 aufweisen.The surfactant or surfactants to be used according to the invention are advantageously selected from the group of surfactants which have a quotient L / D from hemolysis value (L) and denaturation index (D) of greater than or equal to 3, particularly preferably greater than or equal to 5.
Insbesondere vorteilhaft werden das oder die erfindungsgemäß zu verwendenden Tensi- de aus der Gruppe Natrium N-Alkylylglutamate, Natrium Alkylsarkosinate, Natrium Alkyl- sulfosuccinate und Natriumsalze der ethoxylierten und carboxylierten Triglyceride gewählt. Besonders bevorzugt im Sinne der vorliegenden Erfindung ist die Verwendung eines oder mehrerer der folgenden Tenside: Natrium Cocoylglutamat, Natrium Lauroylsarkosinat, Dinatrium Laurylpolyglykolether Sufosuccinat , Natrium PEG-7 Olivenölcarboxylat.The surfactant or surfactants to be used according to the invention are particularly advantageously selected from the group sodium N-alkyllyl glutamates, sodium alkyl sarcosinates, sodium alkyl sulfosuccinates and sodium salts of the ethoxylated and carboxylated triglycerides. For the purposes of the present invention, particular preference is given to the use of one or more of the following surfactants: sodium cocoyl glutamate, sodium lauroyl sarcosinate, disodium lauryl polyglycol ether sufosuccinate, sodium PEG-7 olive oil carboxylate.
Die Gesamtmenge an einer oder mehreren erfiπdungsgemäß verwendeten Tensiden in den fertigen kosmetischen oder dermatologischen Zubereitungen wird vorteilhaft aus dem Bereich von 0,1 bis 10,0 Gew. -%, bevorzugt 0,5 bis 5,0 Gew.-% gewählt, jeweils bezogen auf das Gesamtgewicht der Zubereitungen.The total amount of one or more surfactants used according to the invention in the finished cosmetic or dermatological preparations is advantageously chosen in the range from 0.1 to 10.0% by weight, preferably 0.5 to 5.0% by weight, in each case based on the total weight of the preparations.
Die Reinigungszusammensetzungen enthaltend erfindungsgemäß verwendete Tenside können wie üblich zusammengesetzt sein und der kosmetischen und/oder dermatologischen Reinigung der Haut und/oder der Haare und als Abschminkprodukt für dekorative Kosmetik dienen.The cleaning compositions containing surfactants used according to the invention can be composed as usual and can be used for cosmetic and / or dermatological cleaning of the skin and / or hair and as a make-up removal product for decorative cosmetics.
Zur Anwendung werden die Zusammensetzungen enthaltend erfindungsgemäß verwendete Tenside in der für Kosmetika üblichen Weise auf die Haut und/oder die Haare in ausreichender Menge aufgebracht.For use, the compositions comprising surfactants used according to the invention are applied to the skin and / or the hair in a sufficient amount in the manner customary for cosmetics.
Die Reinigungszubereitungen im Sinne der vorliegenden Erfindung enthalten ferner vor- teilhaft eines oder mehrere waschaktive Tenside der folgenden vier Gruppen A bis D:The cleaning preparations for the purposes of the present invention advantageously also contain one or more detergent surfactants from the following four groups A to D:
A. Anionische TensideA. Anionic surfactants
Vorteilhaft zu verwendende anionische Tenside sind Acylaminosäuren (und deren Salze), wie 1. Acylglutamate, beispielsweise Natriumacylglutamat, Di-TEA-palmitoylaspartat und Natrium Caprylic/ Capric Glutamat,Anionic surfactants to be used advantageously are acylamino acids (and their salts), such as 1. acylglutamates, for example sodium acylglutamate, di-TEA-palmitoylaspartate and sodium caprylic / capric glutamate,
2. Acylpeptide, beispielsweise Palmitoyl hydrolysiertes Milchprotein, Natrium Cocoyl hydrolysiertes Soja Protein und Natrium-/ Kalium Cocoyl hydrolysiertes Kollagen,2. acyl peptides, for example palmitoyl hydrolyzed milk protein, sodium cocoyl hydrolyzed soy protein and sodium / potassium cocoyl hydrolyzed collagen,
3. Sarcosinate, beispielsweise Myristoyl Sarcosin, TEA-Iauroyl Sarcosinat, Natriumlau- roylsarcosinat und Natriumcocoylsarkosinat,3. sarcosinates, for example myristoyl sarcosin, TEA-lauroyl sarcosinate, sodium lauroyl sarcosinate and sodium cocoyl sarcosinate,
4. Taurate, beispielsweise Natriumlauroyltaurat und Natriummethylcocoyltaurat,4. taurates, for example sodium lauroyl taurate and sodium methyl cocoyl taurate,
Carbonsäuren und Derivate, wie 1. Carbonsäuren, beispielsweise Laurinsäure, Aluminiumstearat, Magnesiumalkanolat und Zinkundecylenat,Carboxylic acids and derivatives, such as 1. carboxylic acids, for example lauric acid, aluminum stearate, magnesium alkanolate and zinc undecylenate,
2. Ester-Carbonsäuren, beispielsweise Calciumstearoyllactylat, Laureth-6 Citrat und Natrium PEG-4 Lauramidcarboxylat, 3. Ether-Carbonsäuren, beispielsweise Natriumlaureth-13 Carboxylat und Natrium PEG-6 Cocamide Carboxylat,2. ester carboxylic acids, for example calcium stearoyl lactylate, laureth-6 citrate and sodium PEG-4 lauramide carboxylate, 3. ether carboxylic acids, for example sodium laureth-13 carboxylate and sodium PEG-6 cocamide carboxylate,
Phosphorsäureester und Salze, wie beispielsweise DEA-Oleth-10 Phosphat und Dilau- reth-4 Phosphat,Phosphoric acid esters and salts such as DEA-Oleth-10 phosphate and Dilureth-4 phosphate,
Sulfonsäuren und Salze, wieSulfonic acids and salts such as
1. Acyl-isethionate, z.B. Natrium-/ Ammoniumcocoyl-isethionat,1. acyl isethionates, e.g. Sodium / ammonium cocoyl isethionate,
2. Alkylarylsulfonate,2. alkylarylsulfonates,
3. Alkylsulfonate, beispielsweise Natriumcocosmonoglyceridsulfat, Natrium C12-1 Olefin- sulfonat, Natriumlaurylsulfoacetat und Magnesium PEG-3 Cocamidsulfat,3. alkyl sulfonates, for example sodium cocosmonoglyceride sulfate, sodium C 12-1 olefin sulfonate, sodium lauryl sulfoacetate and magnesium PEG-3 cocamide sulfate,
4. Sulfosuccinate, beispielsweise Dioctylnatriumsulfosuccinat, Dinatriumlaurethsulfosuc- cinat, Dinatriumlaurylsulfosuccinat und Dinatriumundecylenamido MEA-Sulfosuccinat4. Sulfosuccinates, for example dioctyl sodium sulfosuccinate, disodium laureth sulfosuccinate, disodium lauryl sulfosuccinate and disodium undecylenamido MEA sulfosuccinate
sowie Schwefelsäureester, wieas well as sulfuric acid esters, such as
1. Alkylethersulfat, beispielsweise Natrium-, Ammonium-, Magnesium-, MIPA-, TIPA- Laurethsulfat, Natriummyrethsulfat und Natrium C12-ι3 Parethsulfat,1. alkyl ether sulfate, for example sodium, ammonium, magnesium, MIPA, TIPA laureth sulfate, sodium and sodium C12 pareth ι 3,
2. Alkylsulfate, beispielsweise Natrium-, Ammonium- und TEA- Laurylsulfat.2. Alkyl sulfates, for example sodium, ammonium and TEA lauryl sulfate.
B. Kationische TensideB. Cationic surfactants
Vorteilhaft zu verwendende kationische Tenside sindCationic surfactants to be used advantageously
1. Alkylamine,1. alkylamines,
2. Alkylimidazole,2. alkylimidazoles,
3. Ethoxylierte Amine und 4. Quarternäre Tenside.3. Ethoxylated amines and 4. Quaternary surfactants.
Quaternäre Tenside enthalten mindestens ein N-Atom, das mit 4 Alkyl- oder Arylgruppen kovalent verbunden ist. Dies führt, unabhängig vom pH Wert, zu einer positiven Ladung. Vorteilhaft sind Benzalkoniumchlorid, Alkylbetain, Alkylamidopropylbetain und Alkyl-ami- dopropylhydroxysultain. C. Amphotere TensideQuaternary surfactants contain at least one N atom that is covalently linked to 4 alkyl or aryl groups. Regardless of the pH value, this leads to a positive charge. Benzalkonium chloride, alkyl betaine, alkyl amidopropyl betaine and alkyl amidopropyl hydroxysultain are advantageous. C. Amphoteric surfactants
Vorteilhaft zu verwendende amphotere Tenside sindAmphoteric surfactants to be used advantageously
1. Acyl-/dialkylethylendiamin, beispielsweise Natriumacylamphoacetat, Dinatriumacyl- amphodipropionat, Dinatriumalkylamphodiacetat, Natriumacylamphohydroxypropylsulfo- nat, Dinatriumacylamphodiacetat und Natriumacylamphopropionat,1. acyl / dialkyl ethylenediamine, for example sodium acyl amphoacetate, disodium acyl amphodipropionate, disodium alkyl amphodiacetate, sodium acylamphohydroxypropyl sulfonate, disodium acylamphodiacetate and sodium acylamphopropionate,
2. N-Alkylaminosäuren, beispielsweise Aminopropylalkylglutamid, Alkylaminopropion- säure, Natriumalkylimidodipropionat und Lauroamphocarboxyglycinat.2. N-alkylamino acids, for example aminopropylalkylglutamide, alkylaminopropionic acid, sodium alkylimidodipropionate and lauroamphocarboxyglycinate.
3. N-Alkyl- oder N-Alkenylbetaine mit mindestens 12 C-Atomen, wie z. B. Lauryl-ami- dopropylbetain und Oleylamidopropylbetain3. N-alkyl or N-alkenyl betaines with at least 12 carbon atoms, such as. B. lauryl amidopropyl betaine and oleyl amidopropyl betaine
D. Nicht-ionische TensideD. Non-ionic surfactants
Vorteilhaft zu verwendende nicht-ionische Tenside sind I . Alkohole,Nonionic surfactants to be used advantageously are I. alcohols,
2. Alkanolamide, wie Cocamide MEA/ DEA/ MIPA,2. alkanolamides, such as cocamides MEA / DEA / MIPA,
3. Aminoxide, wie Cocoamidopropylaminoxid,3. amine oxides, such as cocoamidopropylamine oxide,
4. Ester, die durch Veresterung von Carbonsäuren mit Ethylenoxid, Glycerin, Sorbitan oder anderen Alkoholen entstehen, 5. Ether, beispielsweise ethoxylierte/propoxylierte Alkohole, ethoxylierte/ propoxy- lierte Ester, ethoxylierte/ propoxylierte Glycerinester, ethoxylierte/ propoxylierte Cholesterine, ethoxylierte/ propoxylierte Triglyceridester, ethoxyliertes propoxylier- tes Lanolin, ethoxylierte/ propoxylierte Polysiloxane, propoxylierte POE-Ether und Alkylpolyglycoside wie Laurylglucosid, Decylglycosid und Cocoglycosid. 6. Sucroseester, -Ether4. esters which are formed by esterification of carboxylic acids with ethylene oxide, glycerol, sorbitan or other alcohols, 5. ethers, for example ethoxylated / propoxylated alcohols, ethoxylated / propoxylated esters, ethoxylated / propoxylated glycerol esters, ethoxylated / propoxylated cholesterols, ethoxylated / propoxylated Triglyceride esters, ethoxylated propoxylated lanolin, ethoxylated / propoxylated polysiloxanes, propoxylated POE ethers and alkyl polyglycosides such as lauryl glucoside, decyl glycoside and cocoglycoside. 6. sucrose esters, ether
7 Polyglycerinester, Diglycerinester, Monoglycerinester 8. Methylglucosester, Ester von Hydroxysäuren7 polyglycerol esters, diglycerol esters, monoglycerol esters 8. methyl glucose esters, esters of hydroxy acids
Die Reinigungszubereitungen im Sinne der vorliegenden Erfindung enthalten besonders vorteilhaft eines oder mehrere erfindungsgemäße waschaktive Tenside aus den Gruppe der Tenside, welchen einen HLB-Wert von mehr als 25 haben, ganz besonders solche, welchen einen HLB-Wert von mehr als 35 haben . Es ist vorteilhaft im Sinn der vorliegenden Erfindung, wenn der Gehalt an einem oder mehreren waschaktiven Tensiden in der kosmetischen oder dermatologischen Reinigungszubereitung aus dem Bereich von 1 ,5 bis 20 Gew.-%, ganz besonders vorteilhaft von 2,0 bis 15 Gew.-% gewählt wird, jeweils bezogen auf das Gesamtgewicht der Zube- reitung.The cleaning preparations within the meaning of the present invention particularly advantageously contain one or more wash-active surfactants according to the invention from the group of surfactants which have an HLB value of more than 25, very particularly those which have an HLB value of more than 35. It is advantageous in the sense of the present invention if the content of one or more detergent surfactants in the cosmetic or dermatological cleaning preparation is in the range from 1.5 to 20% by weight, very particularly advantageously from 2.0 to 15% by weight. % is selected, based in each case on the total weight of the preparation.
Die Zusammensetzungen im Sinne der vorliegenden Erfindung enthalten ferner vorteilhaft Wasser und gegebenenfalls die in der Kosmetik üblichen Zusatzstoffe, z. B. Konservierungsmittel, Konservierungshelfer, Bakterizide, Parfüme, Farbstoffe, Pigmente, die eine färbende Wirkung haben, anfeuchtende und/oder feuchhaltende Substanzen, Füllstoffe, die das Hautgefühl verbessern, Fette, Öle, Wachse oder andere übliche Bestandteile einer kosmetischen oder dermatologischen Formulierung.The compositions within the meaning of the present invention further advantageously contain water and optionally the additives customary in cosmetics, e.g. B. preservatives, preservation aids, bactericides, perfumes, dyes, pigments that have a coloring effect, moisturizing and / or moisturizing substances, fillers that improve the feeling on the skin, fats, oils, waxes or other usual components of a cosmetic or dermatological formulation.
Vorteilhafte Konservierungsmittel im Sinne der vorliegenden Erfindung sind beispiels- weise Formaldehydabspalter (wie z. B. DMDM Hydantoin, welches beispielsweise unter der Handelsbezeichnung Glydant ™ von der Fa. Lonza erhältlich ist), lodopropylbutyl- carbamate (z. B. die unter den Handelsbezeichnungen Glycacil-L, Glycacil-S von der Fa. Lonza erhältlichen und/oder Dekaben LMB von Jan Dekker), Parabene (d. h. p-Hydroxy- benzoesäurealkylester, wie Methyl-, Ethyl-, Propyl- und/oder Butylparaben), Phenoxy- ethanol, Ethanol, Benzoesäure und dergleichen mehr. Üblicherweise umfaßt das Konservierungssystem erfindungsgemäß ferner vorteilhaft auch Konservierungshelfer, wie beispielsweise Octoxyglycerin, Glycine Soja etc.Advantageous preservatives for the purposes of the present invention are, for example, formaldehyde releasers (such as, for example, DMDM hydantoin, which is available, for example, from Lonza under the trade name Glydant ™), iodopropyl butyl carbamate (for example those under the trade names Glycacil) -L, Glycacil-S available from Lonza and / or Dekaben LMB from Jan Dekker), parabens (ie alkyl p-hydroxybenzoate, such as methyl, ethyl, propyl and / or butyl paraben), phenoxyethanol, Ethanol, benzoic acid and the like. According to the invention, the preservation system usually also advantageously comprises preservation aids, such as, for example, octoxyglycerol, glycine soya, etc.
Die Wasserphase der Zubereitungen im Sinne der vorliegenden Erfindung kann vorteil- haft übliche kosmetische Hilfsstoffe enthalten, wie beispielsweise Alkohole, insbesondere solche niedriger C-Zahl, vorzugsweise Ethanol und/oder Isopropanol, Diole oder Polyole niedriger C-Zahl sowie deren Ether, vorzugsweise Propylenglykol, Glycerin, Ethylengly- kol, Ethylenglykolmonoethyl- oder -monobutylether, Propylenglykolmonomethyl, -mono- ethyl- oder -monobutylether, Diethylenglykolmonomethyl- oder -monoethylether und analoge Produkte, Polymere, Schaumstabilisatoren, Elektrolyte, Dihydroxyaceton sowie insbesondere ein oder mehrere Verdickungsmittel, welches oder welche vorteilhaft gewählt werden können aus der Gruppe Siliciumdioxid, Aluminiumsilikate, Polysaccharide bzw. deren Derivate, z. B. Hyaluronsäure, Xanthangummi, Hydroxypropylmethylcellulose, besonders vorteilhaft aus der Gruppe der Polyacrylate, bevorzugt ein Polyacrylat aus der Gruppe der sogenannten Carbopole, beispielsweise Carbopole der Typen 980, 981 , 1382, 2984, 5984, jeweils einzeln oder in Kombination. Auch Moisturizer können bevorzugt verwendet werden.For the purposes of the present invention, the water phase of the preparations can advantageously contain customary cosmetic auxiliaries, such as, for example, alcohols, in particular those having a low C number, preferably ethanol and / or isopropanol, diols or polyols having a low C number, and their ethers, preferably propylene glycol, Glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, mono ethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analog products, polymers, foam stabilizers, electrolytes, dihydroxyacetone and in particular one or more thickeners, which or which advantageous can be selected from the group silicon dioxide, aluminum silicates, polysaccharides or their derivatives, for. B. hyaluronic acid, xanthan gum, hydroxypropylmethyl cellulose, particularly advantageously from the group of polyacrylates, preferably a polyacrylate from the Group of the so-called carbopoles, for example carbopoles of types 980, 981, 1382, 2984, 5984, each individually or in combination. Moisturizers can also be used with preference.
Als Moisturizer werden Stoffe oder Stoffgemische bezeichnet, welche kosmetischen oder dermatologischen Zubereitungen die Eigenschaft verleihen, nach dem Auftragen bzw. Verteilen auf der Hautoberfläche die Feuchtigkeitsabgabe der Hornschicht (auch trans- epidermal water loss (TEWL) genannt) zu reduzieren und/oder die Hydratation der Hornschicht positiv zu beeinflussen.Moisturizers are substances or mixtures of substances that give cosmetic or dermatological preparations the property of reducing the release of moisture from the horny layer (also known as trans-epidermal water loss (TEWL)) and / or hydrating the skin after application or distribution on the skin surface To influence the horny layer positively.
Vorteilhafte Moisturizer im Sinne der vorliegenden Erfindung sind beispielsweise Glycerin, Milchsäure und/oder Lactate, insbesondere Natriumlactat, Butylenglykol, Propylen- glykol, Biosaccaride Gum-1 , Glycine Soja, Ethylhexyloxyglycerin, Pyrrolidoncarbonsäure und Harnstoff. Ferner ist es insbesondere von Vorteil, polymere Moisturizer aus der Gruppe der wasserlöslichen und/oder in Wasser quellbaren und/oder mit Hilfe von Wasser gelierbaren Polysaccharide zu verwenden. Insbesondere vorteilhaft sind beispielsweise Hyaluronsäure, Chitosan und/oder ein fucosereiches Polysaccharid, welches in den Chemical Abstracts unter der Registraturnummer 178463-23-5 abgelegt und z. B. unter der Bezeichnung Fucogel®1000 von der Gesellschaft SOLABIA S.A. erhältlich ist.Advantageous moisturizers for the purposes of the present invention are, for example, glycerol, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, propylene glycol, biosaccaride gum-1, glycine soya, ethylhexyloxyglycerol, pyrrolidonecarboxylic acid and urea. Furthermore, it is particularly advantageous to use polymeric moisturizers from the group of water-soluble and / or water-swellable and / or water-gelable polysaccharides. Particularly advantageous are, for example, hyaluronic acid, chitosan and / or a fucose-rich polysaccharide, which is filed in the Chemical Abstracts under the registration number 178463-23-5 and z. B. under the name Fucogel®1000 from the company SOLABIA S.A. is available.
Besonders vorteilhafte Zubereitungen werden ferner erhalten, wenn als Zusatz- oder Wirkstoffe Antioxidantien eingesetzt werden. Erfindungsgemäß enthalten die Zubereitungen vorteilhaft eines oder mehrere Antioxidantien. Als günstige, aber dennoch fakultativ zu verwendende Antioxidantien können alle für kosmetische und/oder dermatologische Anwendungen geeigneten oder gebräuchlichen Antioxidantien verwendet werden.Particularly advantageous preparations are also obtained if antioxidants are used as additives or active ingredients. According to the invention, the preparations advantageously contain one or more antioxidants. All of the antioxidants suitable or customary for cosmetic and / or dermatological applications can be used as inexpensive, but nevertheless optional, antioxidants.
Besonders vorteilhaft im Sinne der vorliegenden Erfindung können wasserlösliche Antioxidantien eingesetzt werden, wie beispielsweise Vitamine, z. B. Ascorbinsäure und deren Derivate.For the purposes of the present invention, water-soluble antioxidants, such as vitamins, e.g. B. ascorbic acid and its derivatives.
Bevorzugte Antioxidantien sind ferner Vitamin E und dessen Derivate sowie Vitamin A und dessen Derivate. Die Menge der Antioxidantien (eine oder mehrere Verbindungen) in den Zubereitungen beträgt vorzugsweise 0,001 bis 30 Gew.-%, besonders bevorzugt 0,05 bis 20 Gew.-%, insbesondere 0,1 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Zubereitung.Preferred antioxidants are also vitamin E and its derivatives and vitamin A and its derivatives. The amount of the antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30% by weight, particularly preferably 0.05 to 20% by weight, in particular 0.1 to 10% by weight, based on the total weight the preparation.
Sofern Vitamin E und/oder dessen Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.If vitamin E and / or its derivatives represent the antioxidant (s), it is advantageous to choose their respective concentrations from the range from 0.001 to 10% by weight, based on the total weight of the formulation.
Sofern Vitamin A bzw. Vitamin-A-Derivate, bzw. Carotine bzw. deren Derivate das oder die Antioxidantien darstellen, ist vorteilhaft, deren jeweilige Konzentrationen aus dem Bereich von 0,001 bis 10 Gew.-%, bezogen auf das Gesamtgewicht der Formulierung, zu wählen.If vitamin A or vitamin A derivatives or carotenes or their derivatives represent the antioxidant or antioxidants, it is advantageous to add their respective concentrations in the range from 0.001 to 10% by weight, based on the total weight of the formulation choose.
Es ist insbesondere vorteilhaft, wenn die kosmetischen Zubereitungen gemäß der vorlie- genden Erfindung kosmetische oder dermatologische Wirkstoffe enthalten, wobei bevorzugte Wirkstoffe Antioxidantien sind, welche die Haut und/oder die Haare vor oxidativer Beanspruchung schützen können.It is particularly advantageous if the cosmetic preparations according to the present invention contain cosmetic or dermatological active ingredients, preferred active ingredients being antioxidants which can protect the skin and / or the hair from oxidative stress.
Weitere vorteilhafte Wirkstoffe im Sinne der vorliegenden Erfindung sind natürliche Wirk- Stoffe und/oder deren Derivate, wie z. B. alpha-Liponsäure, Phytoen, D-Biotin, Coenzym Q10, alpha-Glucosylrutin, Camitin, Camosin, natürliche und/oder synthetische Isoflavo- noide, Kreatin, Taurin und/oder ß-Alanin.Further advantageous active substances in the sense of the present invention are natural active substances and / or their derivatives, such as. B. alpha-lipoic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, camitin, camosin, natural and / or synthetic isoflavonoids, creatine, taurine and / or ß-alanine.
Die nachfolgenden Beispiele sollen die vorliegende Erfindung verdeutlichen. Die Zahlen- werte in den Beispielen bedeuten Gewichtsprozente, bezogen auf das Gesamtgewicht der jeweiligen Zubereitungen. The following examples are intended to illustrate the present invention. The numerical values in the examples mean percentages by weight, based on the total weight of the respective preparations.
Beispiele:Examples:
Rezepturbeispieleformulation Examples
Figure imgf000013_0001
Figure imgf000013_0001

Claims

Patentansprüche: claims:
1. Verwendung einer oder mehrerer grenzflächenaktiver Substanzen, gewählt aus der Gruppe der Tenside, welche einen .Quotienten aus Hämolysewert und Denaturie- rungsindex von größer oder gleich 1 , bevorzugt größer oder gleich 3, besonders bevorzugt größer oder gleich 5, aufweisen, zum Erzielen oder Erhöhen der Selektivität von kosmetischen oder dermatologischen Reinungszubereitungen.1. Use of one or more surface-active substances, selected from the group of surfactants, which have a. Quotient of hemolysis value and denaturation index of greater than or equal to 1, preferably greater than or equal to 3, particularly preferably greater than or equal to 5, in order to achieve or Increase the selectivity of cosmetic or dermatological cleaning preparations.
2. Verwendung nach Anspruch 1 , dadurch gekennzeichnet, daß die Konzentration Ten- side im Bereich von 0,1 bis 10 Gew.-% liegt, bezogen auf das Gesamtgewicht der2. Use according to claim 1, characterized in that the concentration ten-sided is in the range of 0.1 to 10 wt .-%, based on the total weight of the
Formulierung.Formulation.
3. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Gesamtkonzentration aller reinigungsaktiven Substanzen einschließlich der erfindungsgemäßen Tenside im Bereich von 1 ,5 bis 20 Gew.-% bezogen auf das3. Use according to one of the preceding claims, characterized in that the total concentration of all cleaning-active substances including the surfactants according to the invention in the range of 1, 5 to 20 wt .-% based on the
Gesamtgewicht der Formulierung, insbesondere im Bereich von 2,0 bis 15 Gew.-% liegt.Total weight of the formulation, in particular in the range from 2.0 to 15% by weight.
4. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Tenside ausgewählt sind aus der Gruppe der Natrium N-Alkylylglutamate,4. Use according to one of the preceding claims, characterized in that the surfactants are selected from the group of sodium N-alkylyl glutamates,
Natrium Alkylsarkosinate, Natrium Alkylsulfosuccinate und Natriumsalze der ethoxy- lierten und carboxylierten Triglyceride, insbesondere Natrium Cocoylglutamat, Natrium Lauroylsarkosinat, Dinatrium Laurylpolyglykolether Sufosuecinat, Natrium PEG- 7 Olivenölcarboxylat.Sodium alkyl sarcosinate, sodium alkyl sulfosuccinate and sodium salts of the ethoxylated and carboxylated triglycerides, in particular sodium cocoyl glutamate, sodium lauroyl sarcosinate, disodium lauryl polyglycol ether sufosuecinate, sodium PEG-7 olive oil carboxylate.
5. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Reinigungszubereitungen Cotenside ausgewählt aus der Gruppe der Alkyl- ethersulfate und/oder Alkyltaurate enthalten.5. Use according to one of the preceding claims, characterized in that the cleaning preparations contain cosurfactants selected from the group of alkyl ether sulfates and / or alkyl taurates.
6. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Reinigungszubereitungen Gelbiidner aus der Gruppe der Polyacrylate und/oder Acrylat Copolymere und/oder Polysaccharide enthalten. 6. Use according to any one of the preceding claims, characterized in that the cleaning preparations contain gel formers from the group of polyacrylates and / or acrylate copolymers and / or polysaccharides.
7. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Reinigungszubereitungen zur Gesichtreinigung eingesetzt werden.7. Use according to one of the preceding claims, characterized in that the cleaning preparations are used for face cleaning.
8. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Reinigungszubereitungen zur Reinigung fettiger und/oder unreiner8. Use according to one of the preceding claims, characterized in that the cleaning preparations for cleaning greasy and / or impure
Haut/Kopfhaut eingesetzt werden.Skin / scalp are used.
9. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Reinigungszubereitungen weitere kosmetische Hilfsstoffe enthalten, insbe- sondere Hautbefeuchter, Ölkomponenten, Farbstoffe, Pigmente, Konservierungsmittel und Parfüm.9. Use according to one of the preceding claims, characterized in that the cleaning preparations contain further cosmetic auxiliaries, in particular skin moisturizers, oil components, dyes, pigments, preservatives and perfume.
10. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Reinigungszubereitungen zur Aufschäumung mit einem Pumpschäumer, be- vorzugt einen spritzwassergeschützten Pumpschäumer geeignet sind.10. Use according to one of the preceding claims, characterized in that the cleaning preparations are suitable for foaming with a pump foam, preferably a splash-proof pump foam.
11. Verwendung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß die Reinigungszubereitungen zur Körperreinigung geeignet sind. 11. Use according to one of the preceding claims, characterized in that the cleaning preparations are suitable for body cleaning.
PCT/EP2002/010819 2002-09-26 2002-09-26 Use of detergents with a quotient from the haemolysis value and denaturing index of greater than or equal to 1 for achieving or increasing the selectivity of cleaning preparations WO2004032895A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/010819 WO2004032895A1 (en) 2002-09-26 2002-09-26 Use of detergents with a quotient from the haemolysis value and denaturing index of greater than or equal to 1 for achieving or increasing the selectivity of cleaning preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/010819 WO2004032895A1 (en) 2002-09-26 2002-09-26 Use of detergents with a quotient from the haemolysis value and denaturing index of greater than or equal to 1 for achieving or increasing the selectivity of cleaning preparations

Publications (1)

Publication Number Publication Date
WO2004032895A1 true WO2004032895A1 (en) 2004-04-22

Family

ID=32087924

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/010819 WO2004032895A1 (en) 2002-09-26 2002-09-26 Use of detergents with a quotient from the haemolysis value and denaturing index of greater than or equal to 1 for achieving or increasing the selectivity of cleaning preparations

Country Status (1)

Country Link
WO (1) WO2004032895A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625871B2 (en) 2003-10-07 2009-12-01 The Regents Of The University Of Michigan Indole antiviral compositions and methods

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439642C1 (en) * 1994-11-07 1996-01-11 Goldschmidt Ag Th Non irritant aq. surfactant formulations useful as mild shampoos, face lotions or body care prods.
JPH10147796A (en) * 1996-11-20 1998-06-02 Masayuki Makita Cleaning material for body
US6180591B1 (en) * 1996-09-30 2001-01-30 Clariant Gmbh Use of N-(3-dialkylamino) propyl-N-polyhydroxyalkylcarboxamides and their acid adducts as thickeners for liquid aqueous surfactant systems
DE19950019A1 (en) * 1999-10-16 2001-04-19 Henkel Kgaa Surfactant-containing detergents or cleaning agents for cleaning the skin or hard surfaces contain inhibitors against proteinase-caused skin flaking
DE19950497A1 (en) * 1999-10-20 2001-05-17 Cognis Deutschland Gmbh Cosmetic or pharmaceutical formulation, useful e.g. as shampoo, hair lotion, bubble, creme, gel, lotion, solution, emulsion, wax, stick, powder or salve, comprises alk(en)yl-oligoglycoside and aminodicarboxylic acid partial ester
DE10007321A1 (en) * 2000-02-17 2001-08-23 Henkel Kgaa Cleaning foam
WO2001085107A1 (en) * 2000-05-09 2001-11-15 Henkel Kommanditgesellschaft Auf Aktien Method for the treatment of dandruff using 1-hydroxy-2-pyridone derivatives
EP1174122A1 (en) * 2000-07-13 2002-01-23 L'oreal Cleansing cosmetic composition

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4439642C1 (en) * 1994-11-07 1996-01-11 Goldschmidt Ag Th Non irritant aq. surfactant formulations useful as mild shampoos, face lotions or body care prods.
US6180591B1 (en) * 1996-09-30 2001-01-30 Clariant Gmbh Use of N-(3-dialkylamino) propyl-N-polyhydroxyalkylcarboxamides and their acid adducts as thickeners for liquid aqueous surfactant systems
JPH10147796A (en) * 1996-11-20 1998-06-02 Masayuki Makita Cleaning material for body
DE19950019A1 (en) * 1999-10-16 2001-04-19 Henkel Kgaa Surfactant-containing detergents or cleaning agents for cleaning the skin or hard surfaces contain inhibitors against proteinase-caused skin flaking
DE19950497A1 (en) * 1999-10-20 2001-05-17 Cognis Deutschland Gmbh Cosmetic or pharmaceutical formulation, useful e.g. as shampoo, hair lotion, bubble, creme, gel, lotion, solution, emulsion, wax, stick, powder or salve, comprises alk(en)yl-oligoglycoside and aminodicarboxylic acid partial ester
DE10007321A1 (en) * 2000-02-17 2001-08-23 Henkel Kgaa Cleaning foam
WO2001085107A1 (en) * 2000-05-09 2001-11-15 Henkel Kommanditgesellschaft Auf Aktien Method for the treatment of dandruff using 1-hydroxy-2-pyridone derivatives
EP1174122A1 (en) * 2000-07-13 2002-01-23 L'oreal Cleansing cosmetic composition

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
PAPE W J W ET AL: "IN VITRO METHODS FOR THE ASSESSMENT OF PRIMARY LOCAL EFFECTS OF TOPICALLY APPLIED PREPARATIONS", SKIN PHARMACOLOGY, S. KARGER, BASEL, CH, vol. 4, 1991, pages 205 - 212, XP009002614, ISSN: 1011-0283 *
PAPE W J W ET AL: "STANDARDIZATION OF AN IN VITRO RED BLOOD CELL TEST FOR EVALUATING THE ACUTE CYTOTOXIC POTENTIAL OF TENSIDES", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, EDITIO CANTOR. AULENDORF, DE, vol. 40, no. 4, 1990, pages 498 - 502, XP001118955, ISSN: 0004-4172 *
PAPE W J W ET AL: "VALIDATION OF THE RED BLOOD CELL TEST SYSTEM AS IN VITRO ASSAY FOR THE RAPID SCREENING OF IRRITATION POTENTIAL OF SURFACTANTS", MOLECULAR TOXICOLOGY, HEMISPHERE PUB., WASHINGTON, DC, US, vol. 1, 1987, pages 525 - 536, XP009002624, ISSN: 0883-9492 *
PAPE W. ET AL: "Evaluation of acute irritation potentials of tensides using the in vitro alternative red blood cell test system", PROCEEDINGS SECOND WORLD SURFACTANTS CONGRESS, vol. IV, 1988, Paris, pages 414 - 418, XP001120831 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625871B2 (en) 2003-10-07 2009-12-01 The Regents Of The University Of Michigan Indole antiviral compositions and methods

Similar Documents

Publication Publication Date Title
EP2797571B1 (en) Aqueous hair and skin cleaning compositions comprising biotensides
WO2010108738A2 (en) Formulations containing sorbitan carboxylic acid ester
EP3890684A1 (en) O/w emulsion comprising rhamnolipids
WO2016087241A1 (en) Cleaning preparations containing activated carbon
EP1904026B1 (en) Especially mild shower formulation
WO2012084423A2 (en) Active ingredient combinations of glyceryl glucosides and one or more mild surfactants
WO2001047473A2 (en) Magnesium enriched extract of blue-green alga spirulina and the use thereof in cosmetic and dermatological skin-care and body care agents
EP1432401A1 (en) Use of surfactants with a ratio of hemolysis value to denaturation index of greater than or equal to 1 for obtaining or increasing the selectivity of cleansing preparations
EP3324917A1 (en) Two-phase products that can be reversibly mixed and segregated
WO2004032895A1 (en) Use of detergents with a quotient from the haemolysis value and denaturing index of greater than or equal to 1 for achieving or increasing the selectivity of cleaning preparations
WO2003039498A2 (en) Use of alkyl glucosides to obtain or enhance selectivity of cleaning formulations
EP2654694A2 (en) Active ingredient combinations of glyceryl glucosides and one or more pearlescent agents and/or opacifiers
WO2019063220A1 (en) Shower products having a higher oil content
WO2004073666A1 (en) Foamable cosmetic cleansing preparation
DE10157543A1 (en) Cloths impregnated with an emulsion containing chitosan and/or lecithin, useful for skin cleansing and make-up removal
DE10354116A1 (en) Silicone-free formulation, used for cleaning keratin structures, especially human hair; contains lauryl ether sulfate, cocamidopropyl betaine and 2 nonionic surfactants with different specified hydrophilic lipophilic balance values
DE102014204998A1 (en) Soap-containing cleaning preparations
EP1166772B1 (en) Cosmetic cleansing composition with a high oil concentration
WO2003028694A2 (en) Use of alkyl glucosides in order to obtain or increase the selectivity of cleaning preparations
EP1366739A1 (en) Conditioning shampoo
WO2004052332A1 (en) Cleansing preparations containing fatty acid salts
DE10324788A1 (en) Solid cosmetic purifying preparation in the form of a plate, board or rod for cleaning and caring for the skin and hair has predetermined breaking points so that defined individual pieces can be removed from the whole part

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP